Back

Cardiac resynchronization therapy and clinical outcomes in patients with advanced left ventricular dysfunction and a wide QRS

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Hot topics in device therapy Device Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Gregory Golovchiner

Rabin Medical Centre, Petah Tikva (Israel)

6 More presentations in this session

Presentation thumbnail
Real-world radiotherapy and healthcare utilization in patients implanted with cardiac implantable electronic devices
Mr L. Higuera (Mounds View, US)
Abstract Slides Video
Presentation thumbnail
ICD therapy in patients with preserved LVEF and monomorphic VT
Doctor S. Vakilzadeh-Hashemi (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Implantable cardioverter-defibrillator therapy compared to amiodarone in Chagas cardiomyopathy: a systematic review and meta-analysis
Doctor M. Chacon Quiros (San Jose, CR)
Abstract Slides Video
Presentation thumbnail
Comparison of long-term outcomes between left bundle branch-optimized cardiac resynchronization therapy and conventional biventricular pacing in cardiac resynchronization therapy upgrades
Doctor K. Misonou (Kitakyushu, JP)
Abstract Slides Video
Presentation thumbnail
Clinical impact of late phase responder in cardiac resynchronization therapy
Doctor Y. Kitami (Suita, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Hot topics in device therapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiac resynchroniation therapy for non-LBBB and mid-range QRS: clinical value or questionable benefit?
thumbnail
Congress Session
Fighting ventricular dyssynchrony: cardiac resynchronisation therapy vs. conduction-system pacing
thumbnail
Congress Presentation
Mid-term results of combining left bundle branch area pacing with cardiac resynchronization therapy in heart failure patients: a better choice?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources